(TDC) Teradata - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US88076W1036
Stock: Data Platform, Analytics, Consulting, Support
Total Rating 46
Risk 35
Buy Signal 0.47
| Risk 5d forecast | |
|---|---|
| Volatility | 46.3% |
| Relative Tail Risk | -22.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.47 |
| Alpha | -6.10 |
| Character TTM | |
|---|---|
| Beta | 1.418 |
| Beta Downside | 1.989 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.56% |
| CAGR/Max DD | -0.17 |
EPS (Earnings per Share)
Revenue
Description: TDC Teradata March 04, 2026
Teradata Corporation (TDC) provides hybrid cloud analytics and data platforms globally. The company operates through two segments: Product Sales and Consulting Services.
Its primary offering, Teradata Vantage, is an open platform for enterprise data leveraging. Consulting services focus on data analytics, AI/ML integration, and hybrid ecosystem architecture.
Teradata serves diverse sectors including financial services, healthcare, and telecommunications. The company utilizes a direct sales force. The systems software industry is characterized by rapid technological advancements and a shift towards cloud-based solutions.
To further understand Teradatas market position and financial health, consider exploring its detailed performance metrics on ValueRay.
Headlines to watch out for
- Cloud analytics platform adoption drives subscription revenue growth
- Consulting services demand impacts overall profitability
- Hybrid cloud market competition intensifies pricing pressures
- Enterprise data spending fluctuates with economic cycles
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 130.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -0.67 > 1.0 |
| NWC/Revenue: -4.63% < 20% (prev -10.34%; Δ 5.71% < -1%) |
| CFO/TA 0.17 > 3% & CFO 305.0m > Net Income 130.0m |
| Net Debt (68.0m) to EBITDA (288.0m): 0.24 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (96.4m) vs 12m ago -1.03% < -2% |
| Gross Margin: 59.47% > 18% (prev 0.60%; Δ 5.89k% > 0.5%) |
| Asset Turnover: 95.49% > 50% (prev 102.7%; Δ -7.21% > 0%) |
| Interest Coverage Ratio: 7.62 > 6 (EBITDA TTM 288.0m / Interest Expense TTM 26.0m) |
Altman Z'' -4.45
| A: -0.04 (Total Current Assets 837.0m - Total Current Liabilities 914.0m) / Total Assets 1.78b |
| B: -1.08 (Retained Earnings -1.92b / Total Assets 1.78b) |
| C: 0.11 (EBIT TTM 198.0m / Avg Total Assets 1.74b) |
| D: -1.34 (Book Value of Equity -2.08b / Total Liabilities 1.55b) |
| Altman-Z'' Score: -4.45 = D |
Beneish M -3.13
| DSRI: 1.07 (Receivables 251.0m/246.0m, Revenue 1.66b/1.75b) |
| GMI: 1.02 (GM 59.47% / 60.46%) |
| AQI: 0.93 (AQ_t 0.41 / AQ_t-1 0.45) |
| SGI: 0.95 (Revenue 1.66b / 1.75b) |
| TATA: -0.10 (NI 130.0m - CFO 305.0m) / TA 1.78b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of TDC shares?
As of March 22, 2026, the stock is trading at USD 26.83 with a total of 1,112,062 shares traded.
Over the past week, the price has changed by +0.94%, over one month by -13.20%, over three months by -13.40% and over the past year by +17.32%.
Over the past week, the price has changed by +0.94%, over one month by -13.20%, over three months by -13.40% and over the past year by +17.32%.
Is TDC a buy, sell or hold?
Teradata has received a consensus analysts rating of 3.45.
Therefor, it is recommend to hold TDC.
- StrongBuy: 3
- Buy: 1
- Hold: 5
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the TDC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.7 | 33.2% |
| Analysts Target Price | 35.7 | 33.2% |
TDC Fundamental Data Overview March 22, 2026
P/E Trailing = 19.6889
P/E Forward = 10.4384
P/S = 1.4896
P/B = 10.6551
P/EG = 3.3535
Revenue TTM = 1.66b USD
EBIT TTM = 198.0m USD
EBITDA TTM = 288.0m USD
Long Term Debt = 431.0m USD (from longTermDebt, last quarter)
Short Term Debt = 77.0m USD (from shortTermDebt, last quarter)
Debt = 561.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 68.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (2.48b + Debt 561.0m - CCE 493.0m)
Interest Coverage Ratio = 7.62 (Ebit TTM 198.0m / Interest Expense TTM 26.0m)
EV/FCF = 8.60x (Enterprise Value 2.55b / FCF TTM 296.0m)
FCF Yield = 11.63% (FCF TTM 296.0m / Enterprise Value 2.55b)
FCF Margin = 17.80% (FCF TTM 296.0m / Revenue TTM 1.66b)
Net Margin = 7.82% (Net Income TTM 130.0m / Revenue TTM 1.66b)
Gross Margin = 59.47% ((Revenue TTM 1.66b - Cost of Revenue TTM 674.0m) / Revenue TTM)
Gross Margin QoQ = 60.81% (prev 61.30%)
Tobins Q-Ratio = 1.43 (Enterprise Value 2.55b / Total Assets 1.78b)
Interest Expense / Debt = 1.07% (Interest Expense 6.00m / Debt 561.0m)
Taxrate = 30.19% (16.0m / 53.0m)
NOPAT = 138.2m (EBIT 198.0m * (1 - 30.19%))
Current Ratio = 0.92 (Total Current Assets 837.0m / Total Current Liabilities 914.0m)
Debt / Equity = 2.44 (Debt 561.0m / totalStockholderEquity, last quarter 230.0m)
Debt / EBITDA = 0.24 (Net Debt 68.0m / EBITDA 288.0m)
Debt / FCF = 0.23 (Net Debt 68.0m / FCF TTM 296.0m)
Total Stockholder Equity = 195.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.46% (Net Income 130.0m / Total Assets 1.78b)
RoE = 66.41% (Net Income TTM 130.0m / Total Stockholder Equity 195.8m)
RoCE = 31.59% (EBIT 198.0m / Capital Employed (Equity 195.8m + L.T.Debt 431.0m))
RoIC = 20.92% (NOPAT 138.2m / Invested Capital 660.8m)
WACC = 9.22% (E(2.48b)/V(3.04b) * Re(11.14%) + D(561.0m)/V(3.04b) * Rd(1.07%) * (1-Tc(0.30)))
Discount Rate = 11.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.77%
[DCF] Terminal Value 71.88% ; FCFF base≈295.6m ; Y1≈266.4m ; Y5≈229.0m
[DCF] Fair Price = 35.46 (EV 3.34b - Net Debt 68.0m = Equity 3.27b / Shares 92.2m; r=9.22% [WACC]; 5y FCF grow -12.25% → 2.90% )
EPS Correlation: 41.07 | EPS CAGR: 3.52% | SUE: 3.31 | # QB: 8
Revenue Correlation: -62.05 | Revenue CAGR: -4.28% | SUE: 1.90 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.55 | Chg7d=+0.000 | Chg30d=-0.004 | Revisions Net=+3 | Analysts=10
EPS current Year (2026-12-31): EPS=2.63 | Chg7d=+0.000 | Chg30d=+0.078 | Revisions Net=+10 | Growth EPS=+1.9% | Growth Revenue=-0.6%
EPS next Year (2027-12-31): EPS=2.81 | Chg7d=+0.000 | Chg30d=+0.033 | Revisions Net=+3 | Growth EPS=+6.9% | Growth Revenue=+1.5%
[Analyst] Revisions Ratio: +0.43 (5 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 11.1% - Earnings Yield 5.1%)
[Growth] Growth Spread = -7.3% (Analyst -1.2% - Implied 6.1%)
P/E Forward = 10.4384
P/S = 1.4896
P/B = 10.6551
P/EG = 3.3535
Revenue TTM = 1.66b USD
EBIT TTM = 198.0m USD
EBITDA TTM = 288.0m USD
Long Term Debt = 431.0m USD (from longTermDebt, last quarter)
Short Term Debt = 77.0m USD (from shortTermDebt, last quarter)
Debt = 561.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 68.0m USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (2.48b + Debt 561.0m - CCE 493.0m)
Interest Coverage Ratio = 7.62 (Ebit TTM 198.0m / Interest Expense TTM 26.0m)
EV/FCF = 8.60x (Enterprise Value 2.55b / FCF TTM 296.0m)
FCF Yield = 11.63% (FCF TTM 296.0m / Enterprise Value 2.55b)
FCF Margin = 17.80% (FCF TTM 296.0m / Revenue TTM 1.66b)
Net Margin = 7.82% (Net Income TTM 130.0m / Revenue TTM 1.66b)
Gross Margin = 59.47% ((Revenue TTM 1.66b - Cost of Revenue TTM 674.0m) / Revenue TTM)
Gross Margin QoQ = 60.81% (prev 61.30%)
Tobins Q-Ratio = 1.43 (Enterprise Value 2.55b / Total Assets 1.78b)
Interest Expense / Debt = 1.07% (Interest Expense 6.00m / Debt 561.0m)
Taxrate = 30.19% (16.0m / 53.0m)
NOPAT = 138.2m (EBIT 198.0m * (1 - 30.19%))
Current Ratio = 0.92 (Total Current Assets 837.0m / Total Current Liabilities 914.0m)
Debt / Equity = 2.44 (Debt 561.0m / totalStockholderEquity, last quarter 230.0m)
Debt / EBITDA = 0.24 (Net Debt 68.0m / EBITDA 288.0m)
Debt / FCF = 0.23 (Net Debt 68.0m / FCF TTM 296.0m)
Total Stockholder Equity = 195.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.46% (Net Income 130.0m / Total Assets 1.78b)
RoE = 66.41% (Net Income TTM 130.0m / Total Stockholder Equity 195.8m)
RoCE = 31.59% (EBIT 198.0m / Capital Employed (Equity 195.8m + L.T.Debt 431.0m))
RoIC = 20.92% (NOPAT 138.2m / Invested Capital 660.8m)
WACC = 9.22% (E(2.48b)/V(3.04b) * Re(11.14%) + D(561.0m)/V(3.04b) * Rd(1.07%) * (1-Tc(0.30)))
Discount Rate = 11.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.77%
[DCF] Terminal Value 71.88% ; FCFF base≈295.6m ; Y1≈266.4m ; Y5≈229.0m
[DCF] Fair Price = 35.46 (EV 3.34b - Net Debt 68.0m = Equity 3.27b / Shares 92.2m; r=9.22% [WACC]; 5y FCF grow -12.25% → 2.90% )
EPS Correlation: 41.07 | EPS CAGR: 3.52% | SUE: 3.31 | # QB: 8
Revenue Correlation: -62.05 | Revenue CAGR: -4.28% | SUE: 1.90 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.55 | Chg7d=+0.000 | Chg30d=-0.004 | Revisions Net=+3 | Analysts=10
EPS current Year (2026-12-31): EPS=2.63 | Chg7d=+0.000 | Chg30d=+0.078 | Revisions Net=+10 | Growth EPS=+1.9% | Growth Revenue=-0.6%
EPS next Year (2027-12-31): EPS=2.81 | Chg7d=+0.000 | Chg30d=+0.033 | Revisions Net=+3 | Growth EPS=+6.9% | Growth Revenue=+1.5%
[Analyst] Revisions Ratio: +0.43 (5 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 11.1% - Earnings Yield 5.1%)
[Growth] Growth Spread = -7.3% (Analyst -1.2% - Implied 6.1%)